Skip to main content

Mirador Capital Partners LP

Position in NVS — Novartis AG

CIK 1633446 PLEASANTON, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$327,544
+$41,291 QoQ
Shares Held
2,090
+11.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,079
of 1,603 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. NVS ranks #9 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $327,544 2,090
2026-03-31 $286,253 1,874
2023-09-30 $2,414,285 23,702
2023-06-30 $2,368,155 23,468
2023-03-31 $2,166,876 23,553
2022-12-31 $2,284,148 25,178
2022-09-30 $1,972,763 25,954
2022-06-30 $2,169,377 25,664
2022-03-31 $2,259,299 25,747
2021-12-31 $2,168,468 24,791
2021-09-30 $1,994,123 24,384
2021-06-30 $2,175,252 23,841
2021-03-31 $1,963,988 22,976
2020-12-31 $2,043,559 21,641
2020-09-30 $1,655,718 19,040
2020-06-30 $1,608,802 18,420
2020-03-31 $1,494,653 18,128